Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Express Scripts
Julphar
McKesson
Argus Health
McKinsey
Merck
US Department of Justice

Generated: December 12, 2018

DrugPatentWatch Database Preview

PROVIGIL Drug Profile

« Back to Dashboard

When do Provigil patents expire, and what generic alternatives are available?

Provigil is a drug marketed by Cephalon and is included in one NDA. There is one patent protecting this drug.

This drug has sixty-one patent family members in twenty-eight countries.

The generic ingredient in PROVIGIL is modafinil. There are twenty-six drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the modafinil profile page.

Drug patent expirations by year for PROVIGIL
Synonyms for PROVIGIL
(-)benzhydrylsulphinylacetamide
(+-)-Modafinil
(+/-)-Modafinil
112111-49-6
152JRG3T0U
2-((Diphenylmethyl)sulfinyl)acetamide
2-(Benzhydrylsulfinyl)acetamide
2-(Diphenyl-methanesulfinyl)-acetamide
2-(diphenylmethane)sulfinylacetamide
2-(diphenylmethyl)sulfinylacetamide
2-(diphenylmethyl)sulfinylethanamide
2-[(diphenylmethyl)sulfinyl]acetamide
2-[di(phenyl)methylsulfinyl]acetamide
2-benzhydrylsulfinylacetamide
2-diphenylmethanesulfinylacetamide
68693-11-8
693M118
A836219
AB0021223
AB00639993_03
AB00639993_04
AC-1382
AC1L1HPP
ACE069
Acetamide, 2-((diphenylmethyl)sulfinyl)-
Acetamide, 2-((S)-(diphenylmethyl)sulfinyl)-
Acetamide, 2-[(diphenylmethyl)sulfinyl]-
AFT-801
AK-49128
AKOS004118314
Alertec
AM20060710
AN-38078
AOB87710
API0003414
AS-17039
Attenace
BC208846
BDBM50156055
BIDD:GT0714
BR-49128
BRD-A16332958-001-02-4
BSPBio_002270
C-45684
C15H15NO2S
CAS-68693-11-8
CCG-39511
CEP 1538
CEP-1538
CHEBI:77585
CHEMBL1373
CN-801
CPD000058957
CRL 40476
CRL 40983
CRL-40476
CRL-40983
CS-2191
D01832
D07HQC
DB00745
DEA No. 1680
DSSTox_CID_3329
DSSTox_GSID_23329
DSSTox_RID_76980
DTXSID0023329
F2173-0797
FT-0602599
GTPL7555
HMS1922F12
HMS2051P17
HMS2093D15
HMS3264I03
HMS3393P17
HSDB 7585
HY-15201A
I06-0190
KB-226631
L001269
LS-176682
MCULE-6678415272
MFCD00868082
MLS000759427
MLS001424049
modafinil
Modafinil (JAN/USAN/INN)
Modafinil [USAN:INN]
Modafinil 1.0 mg/ml in Acetonitrile
Modafinil for system suitability, European Pharmacopoeia (EP) Reference Standard
Modafinil-d5
Modafinil, (+)-
Modafinil, >=98% (HPLC)
Modafinil, European Pharmacopoeia (EP) Reference Standard
Modafinilo
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Modalert
modaphonil
Modasomil
Modavigil
Moderateafinil
Modiodal
NC00224
NCGC00095176-01
NCGC00095176-02
NCGC00095176-03
NCGC00095176-04
NCGC00095176-05
NCGC00095176-06
NCGC00095176-08
NH 02D
NH-02D
NSC-751178
NSC-751850
NSC-758711
NSC-759110
NSC751178
NSC751850
NSC758711
NSC759110
OR009373
OR172655
OR202433
OR203968
Pharmakon1600-01504283
Pharmakon1600-01505361
Provigil (TN)
S-3878
SAM001246587
SBI-0206841.P001
SC-74637
SCHEMBL34488
SMR000058957
Sparlon
SPBio_001724
SPECTRUM1505361
Spectrum2_001712
ST45021999
ST50819508
TL8004816
Tox21_111470
Tox21_111470_1
UNII-152JRG3T0U
YFGHCGITMMYXAQ-UHFFFAOYSA-N

US Patents and Regulatory Information for PROVIGIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for PROVIGIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chubb
UBS
Farmers Insurance
Moodys
Cantor Fitzgerald
Boehringer Ingelheim
Argus Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.